Serial direct sodium removal in patients with heart failure and diuretic resistance

被引:3
|
作者
Rao, Veena S. [1 ,11 ]
Ivey-Miranda, Juan B. [1 ,2 ]
Cox, Zachary L. [3 ,4 ]
Moreno-Villagomez, Julieta [1 ,5 ]
Ramos-Mastache, Daniela [5 ]
Neville, Daniel [1 ]
Balkcom, Natasha [1 ]
Asher, Jennifer L. [6 ]
Bellumkonda, Lavanya [1 ]
Bigvava, Tamar [7 ]
Shaburishvili, Tamaz [7 ]
Bartunek, Jozef [8 ]
Wilson, F. Perry [9 ,10 ]
Finkelstein, Fredrick [9 ]
Maulion, Christopher [1 ]
Turner, Jeffrey M. [9 ]
Testani, Jeffrey M. [1 ,11 ]
机构
[1] Yale Univ, Sch Med, Dept Internal Med, Sect Cardiovasc Med, New Haven, CT 06510 USA
[2] Inst Mexicano Seguro Social, Hosp Cardiol, Mexico City, Mexico
[3] Lipscomb Univ, Dept Pharm Practice, Coll Pharm, Nashville, TN USA
[4] Vanderbilt Univ, Sch Med, Dept Med, Nashville, TN USA
[5] Univ Nacl Autonoma Mexico, Fac Estudios Super Iztacala, Mexico City, Mexico
[6] Yale Univ, Sch Med, Dept Med, Div Comparat Med, New Haven, CT USA
[7] Tbilisi Heart & Vasc Clin, 18-20 Ljubljana St, Tbilisi 0159, Georgia
[8] Onze Lieve Vrouw Hosp, Cardiovasc Ctr, Aalst, Belgium
[9] Yale Univ, Sch Med, Dept Med, Div Nephrol, New Haven, CT USA
[10] Yale Univ, Sch Med, Clin & Translat Res Accelerator, New Haven, CT USA
[11] Yale Univ, 135 Coll St,Suite 230, New Haven, CT 06510 USA
关键词
Cardiorenal syndrome; Diuretic; Heart failure; Sodium; SALT INTAKE; PATHOPHYSIOLOGY; ULTRAFILTRATION; STRATEGIES; INSIGHTS; THERAPY; BALANCE; STORAGE; KIDNEY;
D O I
10.1002/ejhf.3196
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Aims Loop diuretics may exacerbate cardiorenal syndrome (CRS) in heart failure (HF). Direct sodium removal (DSR) using the peritoneal membrane, in conjunction with complete diuretic withdrawal, may improve CRS and diuretic resistance. Methods and results Patients with HF requiring high-dose loop diuretics were enrolled in two prospective, single-arm studies: RED DESERT (n = 8 euvolaemic patients), and SAHARA (n = 10 hypervolaemic patients). Loop diuretics were withdrawn, and serial DSR was utilized to achieve and maintain euvolaemia. At baseline, participants required a median 240 mg (interquartile range [IQR] 200-400) oral furosemide equivalents/day, which was withdrawn in all participants during DSR (median time of DSR 4 weeks [IQR 4-6]). Diuretic response (queried by formal 40 mg intravenous furosemide challenge and 6 h urine sodium quantification) increased substantially from baseline (81 +/- 37 mmol) to end of DSR (223 +/- 71 mmol, p < 0.001). Median time to re-initiate diuretics was 87 days, and the median re-initiation dose was 8% (IQR 6-10%) of baseline. At 1 year, diuretic dose remained substantially below baseline (30 [IQR 7.5-40] mg furosemide equivalents/day). Multiple dimensions of kidney function such as filtration, uraemic toxin excretion, kidney injury, and electrolyte handling improved (p < 0.05 for all). HF-related biomarkers including N-terminal pro-B-type natriuretic peptide, carbohydrate antigen-125, soluble ST2, interleukin-6, and growth differentiation factor-15 (p < 0.003 for all) also improved. Conclusions In patients with HF and diuretic resistance, serial DSR therapy with loop diuretic withdrawal was feasible and associated with substantial and persistent improvement in diuretic resistance and several cardiorenal parameters. If replicated in randomized controlled studies, DSR may represent a novel therapy for diuretic resistance and CRS. Clinical Trial Registration: RED DESERT (NCT04116034), SAHARA (NCT04882358). [GRAPHICS] .
引用
收藏
页码:1215 / 1230
页数:16
相关论文
共 50 条
  • [31] Efficacy and Safety of Intravenous Chlorothiazide versus Oral Metolazone in Patients with Acute Decompensated Heart Failure and Loop Diuretic Resistance
    Shulenberger, Christine E.
    Jiang, Anthony
    Devabhakthuni, Sandeep
    Ivaturi, Vijay
    Liu, Tao
    Reed, Brent N.
    PHARMACOTHERAPY, 2016, 36 (08): : 852 - 860
  • [32] More Efficient Sodium Removal by Ultrafiltration Compared to Diuretics in Acute Heart Failure; Underexplored and Overstated
    Kazory, Amir
    BLOOD PURIFICATION, 2016, 42 (04) : 279 - 281
  • [33] Renal tubular resistance is the primary driver for loop diuretic resistance in acute heart failure
    ter Maaten, Jozine M.
    Rao, Veena S.
    Hanberg, Jennifer S.
    Wilson, F. Perry
    Bellumkonda, Lavanya
    Assefa, Mahlet
    Broughton, J. Sam
    D'Ambrosi, Julie
    Tang, W. H. Wilson
    Damman, Kevin
    Voors, Adriaan A.
    Ellison, David H.
    Testani, Jeffrey M.
    EUROPEAN JOURNAL OF HEART FAILURE, 2017, 19 (08) : 1014 - 1022
  • [34] Association between intestinal oedema and oral loop diuretic resistance in hospitalized patients with acute heart failure
    Ikeda, Yuki
    Ishii, Shunsuke
    Maemura, Kenji
    Oki, Takumi
    Yazaki, Mayu
    Fujita, Teppei
    Nabeta, Takeru
    Maekawa, Emi
    Koitabashi, Toshimi
    Ako, Junya
    ESC HEART FAILURE, 2021, 8 (05): : 4067 - 4076
  • [35] Prevalence and outcome of diuretic resistance in heart failure: reply
    Trullas, Joan-Carles
    Casado, Jesus
    Morales-Rull, Jose-Luis
    Formiga, Francesc
    Manzano, Luis
    INTERNAL AND EMERGENCY MEDICINE, 2019, 14 (04) : 633 - 634
  • [36] Hypochloremia and Diuretic Resistance in Heart Failure Mechanistic Insights
    Hanberg, Jennifer S.
    Rao, Veena
    ter Maaten, Jozine M.
    Laur, Olga
    Brisco, Meredith A.
    Wilson, F. Perry
    Grodin, Justin L.
    Assefa, Mahlet
    Broughton, J. Samuel
    Planavsky, Noah J.
    Ahmad, Tariq
    Bellumkonda, Lavanya
    Tang, W. H. Wilson
    Parikh, Chirag R.
    Testani, Jeffrey M.
    CIRCULATION-HEART FAILURE, 2016, 9 (08)
  • [37] Evaluation of diuretic efficiency of intravenous furosemide in patients with advanced heart failure in a heart failure clinic
    Herrera-Leano, Nancy
    Barahona-Correa, Julian E.
    Munoz-Velandia, Oscar
    Fernandez-Avila, Daniel G.
    Marino-Correa, Alejandro
    Garcia, Angel-Alberto
    THERAPEUTIC ADVANCES IN CARDIOVASCULAR DISEASE, 2023, 17
  • [38] Different diuretic properties between tolvaptan and furosemide in congestive heart failure patients with diuretic resistance and renal impairment: a subanalysis of the K-STAR
    Ikeda, Yuki
    Inomata, Takayuki
    Kida, Keisuke
    Shibagaki, Yugo
    Sato, Naoki
    Izumi, Tohru
    Ako, Junya
    HEART AND VESSELS, 2019, 34 (03) : 442 - 451
  • [39] Hyponatraemia and congestive heart failure refractory to diuretic treatment. Utility of tolvaptan
    Pose, A.
    Almenar, L.
    Manzano, L.
    Gavira, J. J.
    Lopez Granados, A.
    Delgado, J.
    Aramburu, O.
    Arevalo, J. C.
    Mendez, M.
    Comin, J.
    Manito, N.
    REVISTA CLINICA ESPANOLA, 2017, 217 (07): : 398 - 404
  • [40] Role of Early Assesment of Diuresis and Natriuresis in Detecting In-Hospital Diuretic Resistance in Acute Heart Failure
    Garcia-Magallon, Belen
    Cobo-Marcos, Marta
    Martiarena, Aitor Davila
    Hernandez, Esther Montero
    Jimenez, Maria Luisa Martin
    Garcia, Aranzazu Martin
    Campos, Daniel De Castro
    Martin, Paula Vela
    Terciado, Fernando Hernandez
    Gonzalez, Ramon Garrido
    Munoz, Andrea Matutano
    Garcia, Daniel Escribano
    Dominguez, Fernando
    Herrero, Ana Sainz
    Penalba, Camino Gomez
    Garcia-Pavia, Pablo
    Segovia, Javier
    FRONTIERS IN PHYSIOLOGY, 2022, 13